← Back to Patent Explorer
US4329495A Expired / Lapsed US ⏱️ 0.0 years remaining

Enkephalinase enzyme inhibiting compounds

Assignee: Pfizer Inc
•
Filing: 1981-05-18
•
Granted: 1982-05-11
•
Expires: 2001-05-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Chiral 2-(2-benzyl-3-mercaptopropionylamino)-1-alkanol derivatives and chiral 2-(2-benzyl-3-mercaptopropionylamino)-4-methylthiobutyric acids are inhibitors of enkephalinase enzyme, reflecting their clinical utility as analgesics or anticonvulsant agents, or as therapy for disorders in which endogenous enkephalin levels are below normal.

Inventors

  • 👤 Jasjit S. Bindra

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 15:14
CPC Classifications
C; C07; C07C; C07C319/00; C07C319/14; C07C319/20; C07C59/00; C07C59/40; C07C59/58; C07C59/64; A; A61; A61P; A61P25/00; A61P25/04; C07C323/00; C07C323/50; C07C323/51; C07C323/60; C07C327/00; C07C57/00; C07C57/52; C07C57/58; C07C57/60

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 54 words
A compound of the formula ##STR9## wherein X is hydrogen, (C 1 -C 3 )alkyl, (C 1 -C 3 )alkoxy, fluoro, chloro, bromo, or trifluoromethyl; R is hydrogen or (C 1 -C 3 )alkyl; n is 1 to 4, m is 0, 1 or 2; and R 1 is (C 1 -C 3 )alkyl.
Claim 2
Dependent Claim 54 words
A compound of the formula ##STR9## wherein X is hydrogen, (C 1 -C 3 )alkyl, (C 1 -C 3 )alkoxy, fluoro, chloro, bromo, or trifluoromethyl; R is hydrogen or (C 1 -C 3 )alkyl; n is 1 to 4, m is 0, 1 or 2; and R 1 is (C 1 -C 3 )alkyl.
Claim 3
Dependent Claim 17 words
A compound of claim 1 wherein n is 2, m is 0 and R 1 is methyl.
Claim 4
Dependent Claim 9 words
A compound of claim 2 wherein R is hydrogen.
Claim 5
Dependent Claim 9 words
A compound of claim 3 wherein X is p-chloro.
Claim 6
Dependent Claim 9 words
A compound of claim 3 wherein X is p-methoxy.
Claim 7
Dependent Claim 9 words
A compound of claim 3 wherein X is hydrogen.
Claim 8
Dependent Claim 9 words
The compound of claim 6 of the formula (I).
Claim 9
Dependent Claim 9 words
The compound of claim 6 of the formula (II).
Claim 10
Dependent Claim 13 words
A compound of the formula ##STR10## or a pharmaceutically acceptable cationic salt thereof.
Claim 11
Dependent Claim 13 words
A compound of the formula ##STR10## or a pharmaceutically acceptable cationic salt thereof.

References Cited (Backward Citations)

US4046889A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-10 1985-11-09 1986-05-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-10 1989-11-09 1990-05-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-10 1993-11-09 1994-05-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag